Northborough, MA, United States of America

Hillard Rubin

USPTO Granted Patents = 8 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 18(Granted Patents)

Location History:

Bridgewater, NJ (US) (2017 - 2021)
Northborough, MA (US) (2020 - 2024)

Company Filing History:

5 out of 8

Homology Medicines, Inc.

where one patent can have more than one assignee

Years Active: 2017-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064486 - Adeno-associated virus compositions for PAH gene transfer and methods of use thereof (2024-08-20),

2. 11951183 - Adeno-associated virus compositions for PAH gene transfer and methods of use thereof (2024-04-09),

3. 11891619 - Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof (2024-02-06),

4. 11306329 - Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof (2022-04-19),

5. 11084864 - Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof (2021-08-10),

6. 10610606 - Adeno-associated virus compositions for PAH gene transfer and methods of use thereof (2020-04-07),

7. 10183983 - Nucleic acids encoding fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof (2019-01-22),

8. 9637534 - Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereof (2017-05-02),

Title: The Innovative Journey of Hillard Rubin

Introduction

Hillard Rubin is a distinguished inventor based in Northborough, MA, known for his significant contributions to biotechnology through his groundbreaking patents. With a total of 5 patents to his name, Rubin’s work primarily focuses on the development of adeno-associated virus compositions aimed at gene therapy.

Latest Patents

One of his latest patents, titled "Adeno-associated virus compositions for PAH gene transfer and methods of use thereof," presents innovative adeno-associated virus (AAV) compositions capable of expressing a phenylalanine hydroxylase (PAH) polypeptide within cells. This advancement plays a crucial role in restoring PAH gene function, paving the way for potential therapies in genetic disorders. Rubin has made remarkable strides with this patent, which outlines various methods of utilizing these AAV compositions along with packaging systems designed for their creation.

Career Highlights

Throughout his career, Hillard Rubin has worked with reputable organizations such as Homology Medicines, Inc. and City of Hope. These roles have provided him with a platform to develop his inventive ideas and collaborate on transformative projects within the biotech industry. Rubin’s expertise and innovative approach have cemented his status as a respected figure in his field.

Collaborations

In his professional journey, Rubin has collaborated with notable colleagues, including Jason Boke Wright and Albert Barnes Seymour. These partnerships exemplify the collaborative spirit critical in advancing biotechnology and innovation, enabling the formulation of pioneering solutions to complex medical challenges.

Conclusion

Hillard Rubin's dedication to innovation and excellence in the field of biotechnology is reflected in his extensive patent portfolio and influential collaborations. As he continues to explore new horizons in gene therapy, his contributions will undoubtedly leave a lasting impact on the industry and the lives of those benefiting from his work. The future looks promising for this inventive mind, and his commitment to advancing science will inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.